Read + Share
Amedeo Smart
Independent Medical Education
Van Hulst G, Jorssen J, Jacobs N, Henket M, et al. Reply: Ex vivo SOCS3 gene responsiveness to alarmins in eosinophils of mepolizumab-treated patients is as yet of unknown biological significance. Eur Respir J 2022;60.PMID: 35777778
Email
LinkedIn
Facebook
Twitter
Privacy Policy